Part 1. Definition
In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Part 2. Example
SECTION 1. LIABILITY OF BUSINESS ENTITIES PROVIDING USE OF FACILITIES
TO NONPROFIT ORGANIZATIONS.

(a) Definitions.--In this section:
(1) Business entity.--The term ''business entity'' means a
firm, corporation, association, partnership, consortium, joint
venture, or other form of enterprise.
(2) Facility.--The term ''facility'' means any real
property, including any building, improvement, or appurtenance.
(3) Gross negligence.--The term ''gross negligence'' means
voluntary and conscious conduct by a person with knowledge (at
the time of the conduct) that the conduct is likely to be
harmful to the health or well-being of another person.
(4) Intentional misconduct.--The term ''intentional
misconduct'' means conduct by a person with knowledge (at the
time of the conduct) that the conduct is harmful to the health
or well-being of another person.
(5) Nonprofit organization.--The term ''nonprofit
organization'' means--
(A) any organization described in section 501(c)(3)
of the Internal Revenue Code of 1986 and exempt from
tax under section 501(a) of such Code; or
(B) any not-for-profit organization organized and
conducted for public benefit and operated primarily for
charitable, civic, educational, religious, welfare, or
health purposes.
(6) State.--The term ''State'' means each of the several
States, the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, Guam, American Samoa, the Northern
Mariana Islands, any other territory or possession of the
United States, or any political subdivision of any such State,
territory, or possession.
(b) Limitation on Liability.--
(1) In general.--Subject to subsection (c), a business
entity shall not be subject to civil liability relating to any
injury or death occurring at a facility of the business entity
in connection with a use of such facility by a nonprofit
organization if--
(A) the use occurs outside of the scope of business
of the business entity;
(B) such injury or death occurs during a period
that such facility is used by the nonprofit
organization; and
(C) the business entity authorized the use of such
facility by the nonprofit organization.
(2) Application.--This subsection shall apply--
(A) with respect to civil liability under Federal
and State law; and
(B) regardless of whether a nonprofit organization
pays for the use of a facility.
(c) Exception for Liability.--Subsection (b) shall not apply to an
injury or death that results from an act or omission of a business
entity that constitutes gross negligence or intentional misconduct,
including any misconduct that--
(1) constitutes a crime of violence (as that term is
defined in section 16 of title 18, United States Code) or act
of international terrorism (as that term is defined in section
2331 of title 18) for which the defendant has been convicted in
any court;
(2) constitutes a hate crime (as that term is used in the
Hate Crime Statistics Act (28 U.S.C. 534 note));
(3) involves a sexual offense, as defined by applicable
State law, for which the defendant has been convicted in any
court; or
(4) involves misconduct for which the defendant has been
found to have violated a Federal or State civil rights law.
(d) Superseding Provision.--
(1) In general.--Subject to paragraph (2) and subsection
(e), this Act preempts the laws of any State to the extent that
such laws are inconsistent with this Act, except that this Act
shall not preempt any State law that provides additional
protection from liability for a business entity for an injury
or death with respect to which conditions under subparagraphs
(A) through (C) of subsection (b)(1) apply.
(2) Limitation.--Nothing in this Act shall be construed to
supersede any Federal or State health or safety law.
(e) Election of State Regarding Nonapplicability.--This Act shall
not apply to any civil action in a State court against a business
entity in which all parties are citizens of the State if such State
enacts a statute--
(1) citing the authority of this subsection;
(2) declaring the election of such State that this Act
shall not apply to such civil action in the State; and
(3) containing no other provision.
Answer: Shields a business entity from civil liability relating to any injury or death occurring at a facility of that entity in connection with a use of such facility by a nonprofit organization if: (1) the use occurs outside the scope of business of the business entity; (2) such injury or death occurs during a period that such facility is used by such organization; and (3) the business entity authorized the use of such facility by the organization.
Makes this Act inapplicable to an injury or death that results from an act or omission of a business entity that constitutes gross negligence or intentional misconduct, including misconduct that: (1) constitutes a hate crime or a crime of violence or act of international terrorism for which the defendant has been convicted in any court; or (2) involves a sexual offense for which the defendant has been convicted in any court or misconduct for which the defendant has been found to have violated a Federal or State civil rights law.
Preempts State laws to the extent that such laws are inconsistent with this Act, except State law that provides additional protection from liability. Specifies that this Act shall not be construed to supersede any Federal or State health or safety law.
Makes this Act inapplicable to any civil action in a State court against a business entity in which all parties are citizens of the State if such State, citing this Act's authority and containing no other provision, enacts a statute declaring the State's election that this Act shall not apply to such action in the State.
Explanation: This Bill focuses on shielding business entities from civil liability relating to an injury or death depending on the conditions of injury, hence the generated summary is correct.
Part 3. Exercise
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

(a) Short Title.--This Act may be cited as the ''Improving Cancer
Treatment Education Act of 2013''.
(b) Table of Contents.--The table of contents of this Act is as
follows:

Sec. 1. Short title; table of contents.
Sec. 2. Findings.
TITLE I--COMPREHENSIVE CANCER PATIENT TREATMENT EDUCATION UNDER THE
MEDICARE PROGRAM

Sec. 101. Medicare coverage of comprehensive cancer patient treatment
education services.
TITLE II--RESEARCH ON CANCER SYMPTOM MANAGEMENT IMPROVEMENT

Sec. 201. Sense of Congress.
Sec. 202. NIH Research on cancer symptom management improvement.

SEC. 2. FINDINGS.

The Congress makes the following findings:
(1) Many people with cancer experience side effects,
symptoms, and late complications associated with their disease
and their treatment, which can have a serious adverse impact on
their health, well-being, and quality of life.
(2) Many side effects and symptoms associated with cancer
and its treatment can be reduced or controlled by the provision
of timely symptom management and services and also by educating
people with cancer and their caregivers about the potential
effects before treatment begins.
(3) Studies have found that individualized educational
intervention for cancer pain management from a registered nurse
was effective for patients with cancer being treated in
outpatient and home-based settings. Similarly, the number of
caregivers who said they were well informed and confident about
caregiving after attending a family caregiver cancer education
program increased after program attendance.
(4) People with cancer benefit from having an educational
session with oncology nurses in advance of the initiation of
treatment to learn how to reduce the risk of and manage adverse
effects and maximize well-being. Helping patients to manage
their side effects reduces adverse events and the need for
urgent or inpatient care.
(5) The Oncology Nursing Society has received reports from
its members that, because the Medicare program and other payers
do not cover the provision of patient treatment education,
patients and their caregivers often do not receive adequate
education before the onset of such patients' treatment for
cancer regarding the course of such treatment and the possible
side effects and symptoms such patients may experience. The
Oncology Nursing Society recommends that all patients being
treated for cancer have a one-on-one educational session with a
nurse in advance of the onset of such treatment so that such
patients and their caregivers receive the information they need
to help minimize adverse events related to such treatment and
maximize the well-being of such patients.
(6) Insufficient or non-existent Medicare payments coupled
with poor investment in symptom management research contribute
to the inadequate education of patients, poor management and
monitoring of cancer symptoms, and inadequate handling of late
effects of cancer and its treatment.
(7) People with cancer often do not have the symptoms
associated with their disease and the associated treatment
managed in a comprehensive or appropriate manner.
(8) People with cancer deserve to have access to
comprehensive care that includes appropriate treatment and
symptom management.
(9) Patients who receive infused chemotherapy likely obtain
some treatment education during the course of the
administration of their treatment; yet, many do not, and
individuals who may receive a different type of cancer care,
such as radiation or surgical interventions or oral
chemotherapy taken at home, likely do not receive treatment
education during their treatment.
(10) Comprehensive cancer care must include access to
services and management associated with nausea, vomiting,
fatigue, depression, pain, and other symptoms.
(11) The Institute of Medicine report, ''Ensuring Quality
Cancer Care'' asserts that ''much can be done to relieve the
symptoms, ease distress, provide comfort, and in other ways
improve the quality of life of someone with cancer. For a
person with cancer, maintenance of quality of life requires, at
a minimum, relief from pain and other distressing symptoms,
relief from anxiety and depressions, including the fear of
pain, and a sense of security that assistance will be readily
available if needed.''.
(12) The Institute of Medicine report, ''Cancer Care for
the Whole Patient: Meeting Psychosocial Health Needs''
recognizes that cancer patients' psychosocial needs include
information about their therapies and the potential side
effects.
(13) As more than half of all cancer diagnoses occur among
individuals age 65 and older, the challenges of managing cancer
symptoms are growing for patients enrolled in the Medicare
program.
(14) Provision of Medicare payment for comprehensive cancer
patient treatment education, coupled with expanded cancer
symptom management research, will help improve care and quality
of life for people with cancer from the time of diagnosis
through survivorship or end of life.

TITLE I--COMPREHENSIVE CANCER PATIENT TREATMENT EDUCATION UNDER THE
MEDICARE PROGRAM

SEC. 101. MEDICARE COVERAGE OF COMPREHENSIVE CANCER PATIENT TREATMENT
EDUCATION SERVICES.

(a) In General.--Section 1861 of the Social Security Act (42 U.S.C.
1395x) is amended--
(1) in subsection (s)(2)--
(A) by striking ''and'' at the end of subparagraph
(EE);
(B) by adding ''and'' at the end of subparagraph
(FF); and
(C) by adding at the end the following new
subparagraph:
''(GG) comprehensive cancer patient treatment education
services (as defined in subsection (iii)(1));''; and
(2) by adding at the end the following new subsection:

''Comprehensive Cancer Patient Treatment Education Services

''(iii)(1) The term 'comprehensive cancer patient treatment
education services' means--
''(A) in the case of an individual who is diagnosed with
cancer, the provision of a one-hour patient treatment education
session delivered by a registered nurse that--
''(i) is furnished to the individual and the
caregiver (or caregivers) of the individual in advance
of the onset of treatment and to the extent
practicable, is not furnished on the day of diagnosis
or on the first day of treatment;
''(ii) educates the individual and such caregiver
(or caregivers) to the greatest extent practicable,
about all aspects of the care to be furnished to the
individual, informs the individual regarding any
potential symptoms, side-effects, or adverse events,
and explains ways in which side effects and adverse
events can be minimized and health and well-being
maximized, and provides guidance regarding those side
effects to be reported and to which health care
provider the side effects should be reported;
''(iii) includes the provision, in written form, of
information about the course of treatment, any
responsibilities of the individual with respect to
self-dosing, and ways in which to address symptoms and
side-effects; and
''(iv) is furnished, to the greatest extent
practicable, in an oral, written, or electronic form
that appropriately takes into account cultural and
linguistic needs of the individual in order to make the
information comprehensible to the individual and such
caregiver (or caregivers); and
''(B) with respect to an individual for whom a course of
cancer treatment or therapy is materially modified, a one-hour
patient treatment education session described in subparagraph
(A), including updated information on the matters described in
such subparagraph should the individual's oncologic health care
professional deem it appropriate and necessary.
''(2) In establishing standards to carry out paragraph (1), the
Secretary shall consult with appropriate organizations representing
providers of oncology patient treatment education services and
organizations representing people with cancer.''.
(b) Payment.--Section 1833(a)(1) of such Act (42 U.S.C.
1395l(a)(1)) is amended--
(1) by striking ''and'' before ''(Z)''; and
(2) by inserting before the semicolon at the end the
following: '', and (AA) with respect to comprehensive cancer
patient treatment education services (as defined in section
1861(iii)(1)), 150 percent of the payment rate established
under section 1848 for diabetes outpatient self-management
training services (as defined in section 1861(qq)), determined
and applied without regard to any coinsurance''.
(c) Coverage.--Section 1862(a)(1) of such Act (42 U.S.C.
1395y(a)(1)) is amended--
(1) in subparagraph (O), by striking ''and'' at the end;
(2) in subparagraph (P), by striking the semicolon at the
end and inserting '', and''; and
(3) by adding at the end the following new subparagraph:
''(Q) in the case of comprehensive cancer patient treatment
education services (as defined in subsection (iii)(1)) which
are performed more frequently than is covered under such
section;''.
(d) No Impact on Payment for Other Services.--Nothing in this
section shall be construed to affect or otherwise authorize any
reduction or modification, in the Medicare payment amounts otherwise
established for chemotherapy infusion or injection codes with respect
to the calculation and payment of minutes for chemotherapy teaching or
related services.
(e) Effective Date.--The amendments made by this section shall
apply to services furnished on or after the first day of the first
calendar year that begins after the date of the enactment of this Act.

TITLE II--RESEARCH ON CANCER SYMPTOM MANAGEMENT IMPROVEMENT

SEC. 201. SENSE OF CONGRESS.

It is the sense of Congress that--
(1) many people with cancer experience side effects,
symptoms, and late side effects associated with their disease
and their treatment, and such effects can have a serious
adverse impact on the effectiveness of their treatment, their
health, well-being, and quality of life;
(2) with the number of cancer survivors continuing to grow,
addressing the effects of their symptoms and side effects is
becoming increasingly critical in reducing the burden of cancer
and its treatments;
(3) although research is producing new insights into the
causes of and cures for cancer, efforts to manage the symptoms
and side effects of the disease and its treatments have not
kept pace; and
(4) the National Institutes of Health should continue to
support research in the area of symptom management and the role
that nurses play in providing those interventions.

SEC. 202. NIH RESEARCH ON CANCER SYMPTOM MANAGEMENT IMPROVEMENT.

(a) In General.--The Director of the National Institutes of Health
shall expand, intensify, and coordinate programs for the conduct and
support of research with respect to--
(1) improving the treatment and management of symptoms and
side effects associated with cancer and cancer treatment; and
(2) evaluating the role of nursing interventions in the
amelioration of such symptoms and side effects.
(b) Administration.--The Director of the National Institutes of
Health is encouraged to carry out this section through the Director of
the National Cancer Institute, in collaboration with at least the
directors of the National Institute of Nursing Research, the National
Institute of Neurological Disorders and Stroke, the National Institute
of Mental Health, the National Center on Minority Health and Health
Disparities, the National Center for Complementary and Alternative
Medicine, and the Agency for Healthcare Research and Quality.
Answer:
Improving Cancer Treatment Education Act of 2013 - Amends title XVIII (Medicare) of the Social Security Act to extend Medicare coverage to comprehensive cancer patient treatment education services, including a one-hour patient treatment education session delivered, in advance of treatment, by a registered nurse to an individual diagnosed with cancer (or whose course of treatment has been materially modified). Amends the Public Health Service Act to require the Director of the National Institutes of Health (NIH) to expand, intensify, and coordinate research programs to: (1) improve the treatment and management of symptoms and side effects associated with cancer and cancer treatment, and (2) evaluate the role of nursing interventions in the amelioration of such symptoms and side effects.